1. Joint application package (JAP)  Joint Application Package (JAP) was rolled out as an an integrated planning tool, rather than just an application form for WHO-managed drug donations, composed of: i.Joint Request for Selected PC Medicines (JRSM) ii.Joint Reporting Form (JRF) iii.Annual Work Plan (AWP) iv.PC Epidemiological Data Reporting Form To be submitted only if new data are available

2. National Programmes GSK Eisai J&J ALB DEC MBD RPRGs Merck KGaA PZQ SHIPMENT Joint Request Joint Report Annual work plan Epi data reporting form ORDER IVMAZI MDP ITI Applications Shipments WHO Joint drug request, review & reporting mechanism

3. ENGLISH: http://www.who.int/neglected_diseases/preventive_chemotherapy/reporting/en/index.htmlhttp://www.who.int/neglected_diseases/preventive_chemotherapy/reporting/en/index.html FRANÇAIS: http://www.who.int/neglected_diseases/preventive_chemotherapy/reporting/fr/index.htmlhttp://www.who.int/neglected_diseases/preventive_chemotherapy/reporting/fr/index.html ESPAÑOL: http://www.who.int/neglected_diseases/preventive_chemotherapy/reporting/es/index.htmlhttp://www.who.int/neglected_diseases/preventive_chemotherapy/reporting/es/index.html Snapshot of the forms (Excel format) JRSM and AWP can be generated through TIPAC

4. Requesting medicines - JRSM Countries are invited to express their 2015 national needs for the following medicines: –LF: DEC and ALB –SCH: PZQ –STH: ALB or MEB Countries should express their needs even though they already managed to secure drug supply from sources other than WHO – with the aim of improving coordination among partners

5. Requesting medicines – JRSM Additional note on PZQ Countries that are willing to include adults in the target population of preventive chemotherapy interventions against schistosomiasis, are invited to express the relevant drug needs in the PZQ tab of the JRSM Such request will not appear in the Summary tab, however it will help estimate global drug needs in view of the increased availability of PZQ from 2016 onwards

6. Reporting on treatment - JRF The JRF should be used to report on any preventive chemotherapy intervention implemented in 2013 –including the use of DEC, ALB, MEB or PZQ –Including treatment data whatever the source of the medicines is (WHO or other partners or direct purchasing) –data by sub-national level (e.g. district) for the ENTIRE COUNTRY LF treatment data should be included in JRF –SS/SC data, morbidity data and TAS results should be included in EPIRF

7. Annual Work Plan (AWP) AWP (Excel table) should indicate the planned schedule and funding situation of key PC activities during the year for which drugs are requested

8. Epidemiological Data Reporting Form (EPIRF) Epidemiological Data Reporting Form (EPIRF) should indicate: –new mapping data completed recently >>> used to revise the estimates of population requiring PC –M&E data (e.g. SS/SC survey results) –TAS results –morbidity-related data

9. Where can I find the forms? All forms are available in English: http://www.who.int/neglected_diseases/preventive_chemotherapy/reporting/en/ http://www.who.int/neglected_diseases/preventive_chemotherapy/reporting/en/ …in French: http://www.who.int/neglected_diseases/preventive_chemotherapy/reporting/fr/ http://www.who.int/neglected_diseases/preventive_chemotherapy/reporting/fr/ …and in Spanish: http://www.who.int/neglected_diseases/preventive_chemotherapy/reporting/es/ http://www.who.int/neglected_diseases/preventive_chemotherapy/reporting/es/ A userguide on how to fill the forms is also available (English only, currently being translated into Fr and Sp): http://apps.who.int/iris/bitstream/10665/83962/1/9789241505499_eng.pdf?ua=1 http://apps.who.int/iris/bitstream/10665/83962/1/9789241505499_eng.pdf?ua=1

10. Tools to facilitate planning and reporting 1. Integrated NTD National Database  To store large volumes of M&E data generated by Neglected Tropical Disease programs over time  To assist with data management and analysis at the country level, thereby supporting programmatic decision-making  To strengthen the capacity for data sharing between countries, WHO, and partners  Can auto-generate JRF

11. 2. Tool for Integrated Planning and Costing (TIPAC)  Excel-based tool to facilitate integrated planning and costing of national programmes for NTDs for annual or multi- year basis  To be used by MoH without need of a technical assistance  Useful for communications with partners  Can auto-generate JRSM and AWP

12. Process Submission deadline is 15 August 2014 (at latest) The forms do not necessarily need to be submitted at the same time, rather as soon as they are completed A bottom-up approach is recommended: MoHs fill the forms in coordination with Partners, with the support of WHO COs/ROs

13. Proposed drug request clearance mechanism  Country presentation template, based on: Annual work plan (2015) JRSM (2015) JRF (2013) EPIRF NPELF progress summary  Other relevant documents submitted by countries  JRSM (2015) RPRG reviews RO clears HQ places  Order for shipment

14. Summary of JAPs as of Sep 2014 (SEARO) Country # people treated (2013)JAP submission status LFSTHSCHJRF '13EPIRF '13JRSM '15AWP '15 Bangladesh7,133,68525,817,300* LF AR, JRF (STH) STH Bhutan DPR Korea3,871,350*JRF (STH) India177,593,1562,382,517 JRF (STH), Excel (LF) STHYes Indonesia23,393,624 LF AR LF SCH Maldives25,426JRF (STH) LF STH Myanmar29,314,89610,849,034 LF AR, JRF (LF, STH) LF STH Nepal16,116,2076,798,560* LF AR, JRF (LF, STH) Sri Lanka Thailand Timor LesteNo MDA

15. Thank you